Zimmer Biomet sales dip in Q4, sets separation date for ZimVie

Zimmer Biomet saw a 2.3 percent dip in its fourth quarter sales year over year and set a completion date of March 1 for its spine and dental spinoff, ZimVie, on Feb. 7.

Advertisement

Here’s what you should know:

1. Fourth quarter revenue was $2 billion, and full-year sales were $7.9 billion, according to financial results.

2. Hip and knee sales saw year-over-year decreases of 4.6 percent and 0.8 percent respectively in the fourth quarter. Hip revenue in the fourth quarter was $480.7 million and $720 million.

3. Spine and dental sales were $260.7 million, down 4.1 percent from the same time last year. 

4. For the full year, hip sales increased 6 percent compared to 2020 and knee sales jumped 11.3 percent. Spine and dental sales rose 12.5 percent.

5. Zimmer Biomet CEO Bryan Hanson said in a news release that COVID-19 surges and hospital staffing shortages affected quarterly sales.

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.